ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

dc.contributor.authorBousquet, J.
dc.contributor.authorHellings, P. W.
dc.contributor.authorAgache, Ioana
dc.contributor.authorBedbrook, A.
dc.contributor.authorBachert, C.
dc.contributor.authorBergmann, K. C.
dc.contributor.authorBewick, M.
dc.contributor.authorBindslev-Jensen, Carsten
dc.contributor.authorBosnic-Anticevich, Sinthia Z.
dc.contributor.authorBucca, C.
dc.contributor.authorCaimmi, D. P.
dc.contributor.authorCamargos, P. A. M.
dc.contributor.authorCanonica, G. W.
dc.contributor.authorCasale, Thomas
dc.contributor.authorChavannes, N. H.
dc.contributor.authorCruz, A. A.
dc.contributor.authorDe Carlo, Giuseppe
dc.contributor.authorDahl, R.
dc.contributor.authorDemoly, Pascal
dc.contributor.authorDevillier, P.
dc.contributor.authorFonseca, J.
dc.contributor.authorFokkens, W. J.
dc.contributor.authorGuldemond, N. A.
dc.contributor.authorHaahtela, T.
dc.contributor.authorHourihane, Jonathan O'B.
dc.contributor.authorIllario, Maddalena
dc.contributor.authorJust, J.
dc.contributor.authorKeil, T.
dc.contributor.authorKlimek, L.
dc.contributor.authorKuna, P.
dc.contributor.authorLarenas-Linnemann, D.
dc.contributor.authorMorais-Almeida, M.
dc.contributor.authorMullol, J.
dc.contributor.authorMurray, R.
dc.contributor.authorNaclerio, R.
dc.contributor.authorO'Hehir, R. E.
dc.contributor.authorPapadopoulos, N. G.
dc.contributor.authorPawankar, R.
dc.contributor.authorPotter, P.
dc.contributor.authorRyan, D.
dc.contributor.authorSamolinski, B.
dc.contributor.authorSchunemann, H. J.
dc.contributor.authorSheikh, A.
dc.contributor.authorSimons, F. E. R.
dc.contributor.authorStellato, C.
dc.contributor.authorTodo-Bom, A.
dc.contributor.authorTomazic, P. V.
dc.contributor.authorValiulis, A.
dc.contributor.authorValovirta, E.
dc.contributor.authorVentura, M. T.
dc.contributor.authorWickman, M.
dc.contributor.authorYoung, I.
dc.contributor.authorYorgancioglu, A.
dc.contributor.authorZuberbier, T.
dc.contributor.authorAberer, W.
dc.contributor.authorAkdis, Cezmi A.
dc.contributor.authorAnnesi-Maesano, I.
dc.contributor.authorAnkri, J.
dc.contributor.funderEuropean Commissionen
dc.description.abstractThe Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA—disseminated and implemented in over 70 countries globally—is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care pathways for the management of rhinitis and asthma by a multi-disciplinary group and by patients themselves. An app (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.en
dc.description.sponsorshipEuropean Innovation Partnership on Active and Healthy Ageing Reference Site MACVIA-France, EU Structural and Development Fund Languedoc-Roussillon, ARIA.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.identifier.citationBousquet, J. et al (2016) 'ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle', Clinical and Translational Allergy, 6(1), pp. 47. 10.1186/s13601-016-0137-4en
dc.identifier.journaltitleClinical And Translational Allergyen
dc.publisherBioMed Centralen
dc.rights© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.en
dc.subjectEIP on AHAen
dc.subjectMobile technologyen
dc.subjectAIRWAYS ICPsen
dc.titleARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleen
dc.typeArticle (peer-reviewed)en
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.53 MB
Adobe Portable Document Format
Published Version
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
2.71 KB
Item-specific license agreed upon to submission